XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2018
Segment Reporting [Abstract] |
Segment Information | Segment Information Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The following table presents information about our reportable segments, reconciled to consolidated totals:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
($ in millions) | 2018 |  | 2017 |  | 2018 |  | 2017
Net sales: |  |  |  |  |  |  |
Proprietary Products | $ | 325.2 |  |  | $ | 308.9 |  |  | $ | 997.4 |  |  | $ | 930.5 |
Contract-Manufactured Products | 106.7 |  |  | 89.3 |  |  | 297.7 |  |  | 253.3 |
Intersegment sales elimination | (0.2 | ) |  | — |  |  | (0.2 | ) |  | (0.3 | )
Consolidated net sales | $ | 431.7 |  |  | $ | 398.2 |  |  | $ | 1,294.9 |  |  | $ | 1,183.5 |
Operating profit (loss): |  |  |  |  |  |  |
Proprietary Products | $ | 68.2 |  |  | $ | 67.5 |  |  | $ | 202.7 |  |  | $ | 189.3 |
Contract-Manufactured Products | 11.2 |  |  | 10.8 |  |  | 29.7 |  |  | 30.1 |
Corporate | (16.3 | ) |  | (15.4 | ) |  | (50.1 | ) |  | (42.9 | )
Other unallocated items | (2.3 | ) |  | — |  |  | (7.8 | ) |  | (11.1 | )
Total operating profit | $ | 60.8 |  |  | $ | 62.9 |  |  | $ | 174.5 |  |  | $ | 165.4 |
Interest expense | 2.0 |  |  | 1.4 |  |  | 6.1 |  |  | 5.7 |
Interest income | (0.5 | ) |  | (0.3 | ) |  | (1.4 | ) |  | (0.9 | )
Other nonoperating income | (1.8 | ) |  | (1.1 | ) |  | (5.1 | ) |  | (2.5 | )
Income before income taxes | $ | 61.1 |  |  | $ | 62.9 |  |  | $ | 174.9 |  |  | $ | 163.1 |
The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments. Other unallocated items during the three and nine months ended September 30, 2018, consisted of $1.2 million and $6.7 million, respectively, in restructuring and related charges. In addition, during the three and nine months ended September 30, 2018, other unallocated items included a charge of $1.1 million related to the classification of Argentina’s economy as highly inflationary under U.S. GAAP as of July 1, 2018. Other unallocated items during the nine months ended September 30, 2017 consisted of a charge of $11.1 million related to the deconsolidation of our Venezuelan subsidiary. Please refer to Note 13, Other (Income) Expense, for further discussion of these items. In March 2017, the FASB issued guidance on the presentation of net periodic pension and postretirement benefit cost (net benefit cost). We adopted this guidance as of January 1, 2018, on a retrospective basis. As a result of this adoption, we reclassified net benefit cost components other than service cost from operating income to outside of operations. Net periodic benefit cost for the three months ended September 30, 2018 and 2017 was $0.8 million and $1.4 million, respectively, of which $2.6 million and $2.5 million, respectively, related to service cost and $1.8 million and $1.1 million, respectively, related to net benefit cost components other than service cost. Net periodic benefit cost for the nine months ended September 30, 2018 and 2017 was $3.0 million and $5.3 million, respectively, of which $8.1 million and $7.8 million, respectively, related to service cost and $5.1 million and $2.5 million, respectively, related to net benefit cost components other than service cost. Please refer to Note 2, New Accounting Standards, for additional information.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration